Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the target of a large increase in short interest during the month of September. As of September 15th, there was short interest totaling 33,174 shares, an increase of 219.3% from the August 31st total of 10,391 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 1,979,498 shares, the days-to-cover ratio is currently 0.0 days.

Advanced Medical Isotope Price Performance

RDGL traded down $0.00 during midday trading on Friday, hitting $0.05. 203,783 shares of the company’s stock traded hands, compared to its average volume of 778,150. The company has a market cap of $22.67 million, a PE ratio of -4.59 and a beta of -0.72. The stock’s fifty day simple moving average is $0.05 and its 200-day simple moving average is $0.07. Advanced Medical Isotope has a one year low of $0.04 and a one year high of $0.12.

Advanced Medical Isotope Company Profile

Advanced Medical Isotope Corporation is a medical technology company developing targeted radiation products for cancer treatment. Its primary product candidate is RadioGel™, an injectable brachytherapy device designed to deliver yttrium-90 radiation directly to solid tumors. The company’s approach is intended to provide localized treatment while limiting radiation exposure to surrounding healthy tissue.

RadioGel is being developed for potential use in treating tumors that may be difficult to address with conventional external-beam radiation or surgery.